Johnson & Johnson invests further US$2 billion in US manufacturing

Johnson & Johnson announce plans to further their investment into reshoring in the US by adding a new manufacturing facility in North Carolina, USA, at FUJIFILM's new biomanufacturing site. 

• Company increases presence in North Carolina with a 160,000+ square foot dedicated manufacturing facility at the FUJIFILM site in Holly Springs
• Investment supports Company’s plans to manufacture the vast majority of advanced medicines in the US to meet the needs of patients in the US.

New Brunswick, N.J. – August 21, 2025 – Johnson & Johnson, healthcare’s leading, most comprehensive innovation powerhouse, announced today it will increase its presence in North Carolina with a 160,000+ square foot dedicated manufacturing facility at FUJIFILM’s new biopharmaceutical manufacturing site in Holly Springs, North Carolina. The US$2 billion commitment to FUJIFILM over the next 10 years will expand the Company’s US manufacturing capacity and create approximately 120 new jobs in North Carolina.

In the coming months, the Company also intends to share the plans for additional advanced manufacturing facilities in the US as well as the expansion of current US sites. These plans reinforce Johnson & Johnson’s leadership in delivering cutting-edge healthcare solutions and will enable the Company to manufacture the vast majority of our advanced medicines in the US to meet the needs of US patients.

“Johnson & Johnson has more manufacturing facilities in the US than in any other country, and we continue to strengthen our presence here,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “With the recent signing of the One Big Beautiful Bill Act, we continue to expand our investment in the US to lead the next era of healthcare innovation.”

In March, the Company announced it will invest US$55 billion to support US manufacturing, research and development, and technology investments over the next four years.

Progress continues in the construction of the Wilson, North Carolina facility, which will employ more than 500 people when fully operational and create approximately 5,000 construction jobs during the site development.
Other investments include extensive R&D infrastructure aimed at developing lifesaving and life-changing treatments in areas such as oncology, neuroscience, immunology, cardiovascular disease, and robotic surgery.

Using the facility at the state-of-the-art FUJIFILM site in Holly Springs will allow the Company to further expand its manufacturing capacity in the US, and across the US, the Company’s investments will support thousands of jobs.

This article has been republished from the following sources (please see below) and is not my original work. I am not responsible for the content's accuracy or any consequences arising from its use. Material may have been edited for length and house style. For further information, please contact the cited source. Our Terms of Use policy can be accessed here.

Source: Johnson & Johnson. Johnson & Johnson Continues U.S. Investment with $2 Billion Commitment to Enable Manufacturing at State-Of-The-Art North Carolina Facility. [Date Accessed 25/08/2026] www.jnj.com/media-center/press-releases/johnson-johnson-continues-u-s-investment-with-2-billion-commitment-to-enable-manufacturing-at-state-of-the-art-north-carolina-facility